Virtual Library

Start Your Search

Yidan Zhao



Author of

  • +

    P2.06 - Mesothelioma (Not CME Accredited Session) (ID 955)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 2
    • Moderators:
    • Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P2.06-06 - Role of GITRL-GITR System in Promoting Proliferation of Malignant Mesothelioma (ID 12852)

      16:45 - 18:00  |  Author(s): Yidan Zhao

      • Abstract

      Background

      Using microarray analysis to compare the gene expression profile of untreated murine mesothelioma cell line (RN5), RN5 treated with cisplatin, RN5 treated with radiation, and enriched mesothelioma stem cell (RN5-EOS-Puro2), we found 41 genes potentially linked to cell stemness. Among those 41 genes, Tnfsf18(GITRL) was one of the cell surface markers which is likely related to tumor proliferation. We therefore decided to analyze the role of this ligand and it’s receptor (GITRL-GITR system) in proliferation of human mesothelioma cancer cells.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      Three human mesothelioma cell lines (CRL5820, CRL5915, CRL5946) were used in this study. They were treated with cisplatin and Cs-137 irradiator respectively. The rt-PCR and Western Blot were used to evaluate the GITRL and GITR expression level at different time points. To evaluate the effect of GITRL-GITR system in mesothelioma cell lines we design in vitro and in vivo model for it. A neutralizing monoclonal antibody (mAb) was used to break the GITRL-GITR system in vitro and in vivo. In the in vitro model, mesothelioma cells were seeded into 96 well plates and the MTT test was used to compare cell proliferating rate 4 days after seeding. In the in vivo model we injected the CRL5946 cells into the peritoneal cavity and implanted patient-derived xenograft subcutaneously of the NOD/SCID mice. We sacrificed mice 4 weeks later to evaluate tumor spheres formation number and draw tumor growing curve.

      4c3880bb027f159e801041b1021e88e8 Result

      All the three mesothelioma cell lines demonstrated increased expression of Tnfsf18 (GITRL) and Tnfrsf18(GITR) at an mRNA and protein levels after treatment with chemotherapy or radiothreapy. Breaking the GITRL-GITR system with neutralizing mAb decreased cell growth and survival rate in mesothelioma cell lines after chemotherapy or radiotherapy. In vitro cell viability test, the MTT test results showed in cisplatin-treated or radiation-treated cell lines with adding mAb to break GITRL-GITR system, the cell viability decreased. In vivo xenografting model of CRL5946 cell line which is treated in advance by chemotherapy or radiotherapy, the average tumor sphere number (>100um) also decreased after using mAb intraperitoneally. The inhibiting effect of GITR neutralizing monoclonal antibody could be demonstrated in vitro and in our in vivo model. In patient-derived xenografting subcutaneous model, the mAb could also delay cell growth.

      8eea62084ca7e541d918e823422bd82e Conclusion

      The results of our study demonstrate that the GITRL-GITR system could play an important role in mesothelioma cells growth and survival especially after chemotherapy or radiotherapy.

      6f8b794f3246b0c1e1780bb4d4d5dc53

    • +

      P2.06-38 - Mesothelioma Stem Cells May Be the Critical Factor of Treatment Failure (ID 11344)

      16:45 - 18:00  |  Author(s): Yidan Zhao

      • Abstract

      Background

      Cancer cell repopulation during treatments of chemotherapy or radiotherapy is a major factor resulting in treatment failure. It has been indicated that cancer stem cells (CSC) may play critical roles during this process. The goal of our study is to characterise mesothelioma stem cells (MSC) and evaluate the prognostic values in those patients with malignant pleural mesothelioma (MPM). The eventual aim would be to design specific target therapy against MSC and develop novel approaches in clinical practice.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      We have screened a group of genes that are most likely MSC-specific. Further characterization of the selected genes will be of critical importance in tumorigenesis, progression and prognosis. Murine mesothelioma AB12 and RN5 cells treated with either chemotherapy or γ-ray irradiation in culture, were used to compare gene expression profiles. The selected genes were confirmed by real-time PCR, flow cytometry and immunostaining. In vivo models, peritoneal lavage was collected at different time points after RN5 cell injection, to perform magnetic ranking cytometry with antibody-nanoparticle conjugates, and microarray assay. The expression of Tnfsf18 and Ngfr (CD271) genes associated with prognosis was evaluated in tumor tissues from MPM patients treated with SMART vs pre-SMART protocols, as SMART protocol has already shown significant clinical benefit. Image analysis was performed using Apero Imagescope program.

      4c3880bb027f159e801041b1021e88e8 Result

      The proportion of MSC significantly increased after RN5 parental cells were treated with either chemotherapy, or γ-ray irradiation, or in combination, while MSC showed more resistance to the above treatments, suggesting that chemoradiation resulted in MSC enrichment. Upregulation of genes Tnfsf18, Serpinb9b, Ly6a (Sca-1), Ngf, and Nppb were confirmed. CD271, the receptor of NGF, was shown to be upregulated after chemoradiation, especially after γ-ray radiation with a dose of 10Gy. Mesothelial precursors captured with magnetic nanoparticles conjugated to anti-Msln and trapped in the microfluidic device in the presence of a magnetic field showed an increase over time from 2-8weeks. Image analysis of human section slides indicated that total positive area of CD271 staining was significantly lower in those who were treated with SMART protocol than those with pre-SMART protocol (p<0.0025). Similar results were obtained in the high, medium and low positive areas from the SMART group, and p values are 0.0013, 0.0017 and 0.0035, respectively, when compared with the pre-SMART group.

      8eea62084ca7e541d918e823422bd82e Conclusion

      MSC-specific genes like CD271 and Tnfsf18 might be used as potential prognostic indicators and therapeutic targets.

      6f8b794f3246b0c1e1780bb4d4d5dc53